[Elsevier] Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial |
|
This post will be closed automatically in 2026-07-13 14:49
Reward10points
|
post
reply
points
230
10
Flexible phase change materials with enhanced tensile strength, thermal conductivity and photo-thermal performance
50
Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial
10
Copper oxide stabilized oxy-functionalized boron nitridecarbon nanotube nanohybrid: An ultra-stable electrode for flexible asymmetric supercapacitor device in ionic electrolyte
10
Influence of Sn4+ substitution for Zr4+ in Nd2Zr3(MoO4)9 and the impact on the crystal structure and microwave dielectric properties
10
Counting cattle in UAV images using convolutional neural network
